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Abstract
The normal development and maintenance of CNS white matter, and its
responses to disease and injury, are defined by synergies between axons,
oligodendrocytes, astrocytes and microglia, and further influenced by
peripheral components such as the gut microbiome and the endocrine and
immune systems. Consequently, mechanistic insights, therapeutic approaches
and safety tests rely ultimately on   models and clinical trials. However, in vivo in
 models that replicate the cellular complexity of the CNS can inform thesevitro
approaches, reducing costs and minimising the use of human material or
experimental animals; in line with the principles of the 3Rs. Using
electrophysiology, pharmacology, time-lapse imaging, and immunological
assays, we demonstrate that murine spinal cord-derived myelinating cell
cultures recapitulate spinal-like electrical activity and innate CNS immune
functions, including responses to disease-relevant myelin debris and pathogen
associated molecular patterns (PAMPs).  Further, we show they are (i)
amenable to siRNA making them suitable for testing gene-silencing strategies;
(ii) can be established on microelectrode arrays (MEAs) for electrophysiological
studies; and (iii) are compatible with multi-well microplate formats for semi-high
throughput screens, maximising information output whilst further reducing
animal use. We provide protocols for each of these. Together, these advances
increase the utility of this   tool for studying normal and pathologicalin vitro
development and function of white matter, and for screening therapeutic
molecules or gene targets for diseases such as multiple sclerosis, motor
neuron disease or spinal cord injury, whilst avoiding   approaches onin vivo
experimental animals.
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in experimental rats and mice, and occasionally in primates, under-
going procedures such as spinal cord contusion, genetic modifica-
tion or induction of experimental allergic encephalopathy (EAE); 
procedures that range in severity from moderate to severe under 
Animals (Scientific Procedures) Act 1986 licensing. Whilst such 
studies can and do provide important information relevant to 
human disease, they require careful design and large numbers 
of animals to provide sufficient power (Baker & Amor, 2014). 
For example, we estimate that to test the efficacy of a single drug, 
3 cohorts each of 12 animals with EAE is required, depending 
on effect size and consistency in response (C. Linington, 
personal communication). Alternative approaches include in vitro 
techniques, such as human-derived induced pluripotent stem cell 
models or murine cell cultures.
Indeed, cell and tissue culture is used widely in neuroscience to 
study the development and function of the major cell types of the 
CNS; neurons, oligodendroglia, astrocytes and microglia. The 
main reasons being, in vitro models are a) relatively inexpensive; 
b) amenable to manipulation, including pharmacological and 
genetic; c) accessible to live imaging and optogenetic approaches; 
d) reduce the reliance on experimental animal models for 
early-stage screening/proof-of-concept studies; and e) inform 
subsequent animal studies, if they are required. In particular, cell 
culture assays can reduce the numbers of animal used in in vivo 
studies by, for example (i) guiding selection of candidate thera-
peutic molecules, (ii) informing drug dosage concentrations, 
(iii) measuring toxicity (iv) defining gene targeting efficiency 
(v) testing gene constructs prior to the generation of transgenic 
animals.
Single cell type-enriched cultures have been invaluable in address-
ing questions relating to cell autonomous characteristics (Bechler 
et al., 2015; Lee et al., 2012a; Mei et al., 2014; Sanchez-Gomez 
et al., 2018) and simple co-cultures have shed light on bi-cellular 
interactions (Froger et al., 2010; Lundgaard et al., 2013). 
However, multi-cell type (Madhavan et al., 2018; Thomson 
et al., 1993) or explant cultures (Thomson et al., 2006; Zhang 
et al., 2011) that maintain the complex cellularity and func-
tional properties of the CNS, more closely represent the in vivo 
situation. As such, they are more relevant for addressing ques-
tions where the answer relies on physical interactions and/or 
paracrine signaling between CNS cell types; notwithstand-
ing they remain uncoupled from the influence of peripheral 
organs or systems including the gut microbiome, the adaptive 
immune system and the endrocrine system.
Myelinated nerve fibers are the culmination of complex bidirec-
tional molecular, structural and functional interactions between 
axons and oligodendrocytes. For example, neuronal electrical 
activity modulates myelination during development (Demerens 
et al., 1996; Wake et al., 2011 and reviewed in Almeida, 2018; 
Almeida & Lyons, 2017; Zalc & Fields, 2000) and the myelinat-
ing cell supports the myelinated axon throughout life (Edgar 
et al., 2009; Griffiths et al., 1998; Lappe-Siefke et al., 2003) 
by modulating axonal transport and the axonal cytoskeleton 
(Edgar et al., 2004; Kirkpatrick et al., 2001; Pan et al., 2005), 
maintaining white matter homeostasis (Kassmann et al., 
2007; Schirmer et al., 2018) and providing energy substrates 
Research highlights
Scientific benefits: 
•    Recapitulates in vivo-like myelination, innate immune 
responses and neuronal electrical activity and is 
amenable to live cell imaging.
•    Compared to single cell type or mixed PNS-CNS cell 
cultures, this pure CNS multi-cell type system more 
closely resembles the in vivo situation.
•    Uncouples CNS-intrinsic responses from those mediated 
by peripheral organs and systems.
•    Ease of manipulation, i.e. genetic using siRNA; neuronal 
electrical activity using pharmacological modulators of 
neural activity; small molecules using small molecule 
libraries; relevant PAMPs or DAMPS.
•    Can be generated from transgenic reporter mice for 
live imaging and functional readouts or from mutant or 
transgenic models of disease.
3Rs benefits: 
•    Inform studies and/or acts as an adjunct to studies 
using in vivo models of multiple sclerosis, motor 
neurone disease, the leukodystrophies and other 
neurodegenerative diseases involving white matter, 
minimising the use of experimental animals and 
maximising information obtained.
Practical benefits: 
•    Straightforward to establish in any lab with cell culture 
facilities.
•    Compared to CNS slice cultures, which also contain all 
major neural cell types, this cell culture system is easier 
to maintain (oxygen and nutrients readily reach all cells) 
and quicker to set up.
•    Cells can be grown on microelectrode arrays that do not 
require the specialist expertise needed for single cell 
electrophysiology.
•    Cells can be grown on multi-well plates for semi-high 
throughput assays.
•    Multi-well microplate formats facilitate the testing of 
multiple factors on parallel cultures.
Current applications: 
•    Semi-high throughput screens for pro-myelinating or 
inhibitory factors; testing and verifying siRNA constructs 
and/or testing the consequences of gene knockdown; 
modulating neural activity to assess secondary 
consequences for other cells types; live imaging of 
cellular interactions.
Potential applications: 
•    Semi-high throughput screens for factors that affect axonal 
survival or regeneration.
•    Assessing effects of microglial ablation on other cell types, 
by manipulating CSF1R signalling pathway.
•   Live imaging of organelle distribution and/or transport.
•    Initial screen of anti-sense oligonucleotides for gene 
silencing in the context of in vivo-like cellular phenotypes 
and morphologies.
Introduction
Diseases that affect white matter are many and varied, and include 
spinal cord injury, motor neuron disease, Alzheimer’s and multi-
ple sclerosis. Typically, these diseases are modelled and studied 
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(Fünfschilling et al., 2012; Lee et al., 2012b; Meyer et al., 2018). 
Adjacent microglia and astrocytes shape and support the myeli-
nated fiber during development and adulthood (reviewed in 
Allen & Lyons, 2018; Thion et al., 2018). For example, micro-
glia clear apoptotic oligodendrocytes generated in excess during 
development (Barres & Raff, 1994; Barres et al., 1992), boost 
developmental myelination by expressing IGF-1 (Wlodarczyk 
et al., 2017) and remove debris following demyelination or 
Wallerian degeneration, albeit slowly (George & Griffin, 
1994). Astrocytes secrete factors that enhance developmen-
tal myelination (Ishibashi et al., 2006 and reviewed in Barnett 
& Linington, 2013), form gap junctions with each other and 
with oligodendrocytes for exchange of ions and small metabo-
lites (reviewed in Cotrina & Nedergaard, 2012) and regulate 
the structure of the mature myelin sheath through secretion 
of inhibitors of thrombin proteases (Dutta et al., 2018). 
Conversely, ‘activated’ microglia and astrocytes can contribute to 
disease pathogenesis and injury to myelinated fibers, as in mouse 
models of motor neuron disease (Beers et al., 2006; Boillée 
et al., 2006; Hall et al., 1998; Nagai et al., 2007; Yamanaka 
et al., 2008), the leukodystrophies (Ip et al., 2007), and cerebral 
vascular disease (Fowler et al., 2018). Thus, in vitro models 
that replicate the interdependence of cells of the intact CNS 
provide an informative prelude or adjunct to in vivo studies.
We previously described a murine, spinal cord-derived myelinat-
ing cell culture system (Thomson et al., 2006; Thomson et al., 
2008) to explore axonal organelle distribution (Edgar et al., 
2008), cell dynamics (Ioannidou et al., 2012), pro-myelination 
factors (Berghoff et al., 2017; Goebbels et al., 2017) and 
neurotropism and pathogenesis of Zika virus infection 
(Cumberworth et al., 2017). However, little is known about the 
culture’s functional properties with respect to neuronal electrical 
activity or innate immune responses; factors that influence 
normal development as well as pathology. Further, the possibil-
ity of modifying it for use as an electrophysiological or gene 
silencing assay has not been explored. Here we validate this 
system as a functional model of CNS white matter, and describe 
adaptations to increase its utility in the study of development and 
disease. This model is straightforward to establish in any labora-
tory with basic cell culture facilities, and its use can be extended 
as described here, if equipment is available for live imaging, 
microelectrode array and/or multi-well plate microscopy.
Methods
Mice
All animals were bred and maintained in conventional cag-
ing, with up to 4 cage companions, in the Biological Services 
Facilities (BSF) at the University of Glasgow; 12 h light-dark 
cycle and food and water ad libitum. Bedding was non-sterile 
wood-chip; food was normal maintenance diet; water was 
normal tap water; temperature was 19–21 °C; and humidity was 
55% ± 10%. Environmental enrichment took the form of mini-
tubes, sizzle nest and burrowing treats (sunflower and pumpkin 
seeds). The mice themselves were not health-screened but the 
BSF was free of the major rodent pathogens but positive for 
some adventitious agents, namely – for the period in question – 
pinworms, Helicobacter spp., Pasteurella pneumotropica and 
Mouse Norovirus. Embryonic day 13 (E13; day of plug being E0) 
mice (of both sexes; sex undetermined) were obtained by time 
mating wild type mice; Cnp+/+ with Cnp-/- mice (Lappe-Siefke 
et al., 2003), both on a C57BL/6J (Charles River) background; 
or wild type females with hemizygous Thy1-CFP males (Feng 
et al., 2000), both on a C57BL/6N (Charles River) back-
ground. Pregnant dams were killed on the morning of E13 by 
cervical dislocation followed by decapitation and the uterine 
horns containing the developing embryos were removed after 
laparotomy, and immediately placed on ice in a sterile 10 cm 
Petri dish. Adult (postnatal day [P] 60 – P120, male and female 
homozygous Plp1 transgenic (line #72; (Readhead et al., 1994) 
and wild type mice (littermates or closely related mice from the 
same colony) were killed in gradually increasing levels of CO2, 
followed by decapitation, and the spinal cord was extracted 
rapidly for preparation of a myelin-enriched tissue fraction. 
All animal use was approved by the Ethical Committee of the 
University of Glasgow and licensed under the Animal [Scientific 
Procedures] Act 1986 project licence PPL60/3656. Experi-
ments on animal-derived cell cultures were conducted according 
to ARRIVE guidelines, including randomisation of samples 
in multi-well microplates, blinding of the experimenter and/or 
automation of quantification, as indicated. Numbers of technical 
repeats and independent biological repeats are indicated in the 
Figure Legends. Technical repeat: independent wells/dishes 
from a single cell culture. Biological repeat (or experimental 
unit): independent cell culture, generated by pooling all embryos 
from a single pregnant mouse.
Plp1 tg mice ≥3 months of age mice are prone to seizures. Mice 
appearing dull or apathetic (suggesting a post-ictal problem) 
or which has an observed seizure lasting more than 2 minutes 
were killed by a humane method. In the vast majority of instances, 
the mice were used prior to the development of seizures.
Myelinating cell cultures
A step-by-step protocol is provided in the supplementary protocol 
document (Supplementary File 1). The procedure for prepar-
ing murine myelinating cultures described (Thomson et al., 
2008) was modified slightly. Briefly, E13.5 mouse spinal cords 
were dissected, then incubated in 1 ml per 6 cords of 0.25% trypsin 
in HBSS minus calcium and magnesium for 15 minutes at 37°C. 
The digestion was stopped using 1 ml per 6 cords SD solution 
(Thomson et al., 2008) or Plating Medium (PM; 50% DMEM, 
25% HBSS and 25% horse serum) plus 0.04 mg/ml DNase (or 
more, if required). The cells were triturated, resuspended in PM 
and plated on coverslips (3 x 13 mm diameter per 35 mm Petri 
dish), imaging dishes or microelectrode arrays (MEAs) at 
~150,000 cells per 100 μl PM, per 133 mm2; or in 96 or 384-well 
dishes in 50 μl PM, at various concentrations (see Results). From 
day in vitro (DIV) 0, cells were grown in 50% PM and 50% 
differentiation medium (DMEM supplemented with 30% 
D-glucose (4500 mg/l glucose final), 10 ng/ml biotin, 50 nM 
hydrocortisone, 10 μg/ml insulin, 0.5% hormone mix (stock 
concentration 1 mg/ml apo-transferrin, 20 mM putrescine, 4 μM 
progesterone, and 6 μM selenium; based on (Bottenstein & Sato, 
1979), at 37°C in 5 or 7% CO2, then fed three times a week by 
replacing half the medium with serum-free differentiation 
media. All DMEM contained 100 U/ml penicillin and 100 μg/ml 
streptomycin. From DIV 12 onwards, feeding was done with 
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insulin-free differentiation media. The effect of Activin-A 
(AA; R&D Systems, Cat. 338-AC-010; Lot BNV3313053) and 
recombinant human fibroblast growth factor 9 (FGF9; R&D 
Systems, Cat. 273-F9-025; Lot ON1413121 or ON1413041) on 
myelinating cultures was investigated between 15 (AA) or 18 
(FGF9) and 28 DIV, on cells grown on multi-well microplates. 
For treating with ‘myelin debris’, coverslips were transferred 
from 35 mm Petri dishes the day before, into 24 well dishes in 
maximum 500 μl differentiation media.
Treatment of cell grown on multi-well microplates
To minimise ‘edge-effects’ due to increased rate of evaporation 
or warming of media, cells were not plated in the wells on 
the outer edges of the microplate. Instead, these were filled 
with Hank’s Balanced Salts solution. DMSO (1% v/v), AA 
(1–100 ng ml-1) or FGF9 (100 ng ml-1 were added to wells follow-
ing a pre-generated random pattern that varied from one experi-
mental repeat to the next, to avoid potential effects related to 
the location of the wells on the microplates.
Live imaging dishes
A protocol for custom made imaging dishes is described in 
the supplementary protocol document (Supplementary File 2). 
Briefly, 3 x 11 mm diameter holes were burred in the bottom of 
35 mm Petri-dishes (Falcon Ref. 353001) and 25 mm diameter 
glass coverslips (Menzel-Glaser 0,17 +/- 0,01 mm; Starke 1,5; 
Lot #004710182; Thermo Scientific) were stuck to the base of 
the dishes using non-toxic glue. Dishes are cleaned and sterilised 
then coated with poly-L-lysine. Live imaging dishes were 
alternatively purchased from MatTek Corporation, Ashland, USA 
or custom made (Kline, 2009).
Substrates for cell adhesion
Poly-L-lysine (PLL; 13.3 μg/ml) in water or boric acid buffer 
(50 mM boric acid, 23.5 mM sodium tetraborate, pH 8.5) was 
used to coat 13 mm diameter glass coverslips (Fisher Scientific, 
Leicestershire; 631-0150), imaging dishes, microelectrode 
arrays or microplates (96 [Greiner 655891] or 384-well [Greiner 
781856] Sensoplate Plus, black, 175 μM glass bottom, Greiner 
Bio-One) for 1–12 hours at 37°C, after which the PLL was aspi-
rated, the glass washed three times in dH20 and air dried in the 
laminar flow hood. Empirically, we found the cultures were 
far less reproducible if PLL was prepared in water compared 
to boric acid buffer.
Myelin isolation from mouse spinal cord
A step-by-step protocol is provided in the supplementary proto-
col document (Supplementary File 3). Adult (P45-P120) wild type 
or Plp1 transgenic mice were killed in gradually increasing lev-
els of CO2 and the spinal column was severed at the lumbar and 
cervical regions. The spinal cord was rapidly removed by intro-
ducing sterile saline under pressure to the lumbar region of the 
spinal canal, using an 18-gauge hypodermic needle attached to a 
5 ml syringe. Cords were immediately processed or snap-frozen 
and stored in liquid nitrogen. Myelin was harvested following 
the method of (Norton & Poduslo, 1973), with slight modifica-
tion. All steps were performed at 4°C, using filter sterilised solu-
tions prepared from cell culture grade diluents or MilliQ water. 
Cords were homogenised in sterile 0.85 M sucrose solution in 
10 mM HEPES using a polytron homogeniser at full speed for 
12 strokes. Three ml of a 0.25 M sterile sucrose solution in 10 mM 
HEPES was slowly added on top of 7.5 ml of the homogenate. 
The samples were spun at 70,000 x g for 90 minutes at 4°C 
in a Beckman SW41 rotor. The interface between the sucrose 
layers, containing the membrane fractions, was gently aspirated 
and washed by vortexing in 6 ml chilled MilliQ water then 
spun at 23,000 x g for 30 minutes in a Beckman J21 rotor, to 
remove the excess sucrose. This osmotic shock was repeated 
twice more. Following a final 19,000 x g spin, the resultant 
myelin-enriched pellet was resuspended in cell culture grade phos-
phate buffered saline (PBS; Sigma-Aldrich, catalogue number 
806552). The protein concentration was measured using Pierce 
BCA protein assay kit (Thermo Fisher Scientific, catalogue 
number 23225) and this myelin fraction was tested for sterility 
(by incubating a sample in cell culture media at 37°C for 
7 days), and labeled with NHS-Rhodamine Antibody Labeling 
Kit (Thermo Fisher Scientific, product #53031), according to the 
manufacturer’s instructions.
Addition of exogenous myelin to myelinating cell cultures
A rhodamine-labeled myelin enriched tissue fraction (2 mg 
protein ml-1 myelin homogenate) was added to the myelinating 
cultures at DIV 21, DIV 25 or DIV 27 (all ± 1 day), to a final 
concentration of 0.075 or 0.1 mg protein ml-1 (unless otherwise 
indicated) for respectively, 7, 3 or 1 DIV. Cell culture grade PBS 
alone (to the same volume as the myelin emulsion), or 3 × 106 
one μm diameter Flurobite fluorescently labeled latex beads 
(Polyscience, Park scientific, Northampton, UK) were added 
in parallel. Two coverslips, each plated at the start with 150,000 
spinal cord cells, were treated with wild type myelin, Plp1 
tg myelin, PBS or latex beads. Cells were fixed and stained 
with rat anti-CD45 (Serotec, catalogue number MCA 1388, 
monoclonal; 1 in 600) to label microglia at DIV 28 (± 1 day) for 
analysis. Independent myelin preparations were used for each 
experimental repeat.
Antibodies and immunocytochemistry
A supplementary protocol document is attached (Supplementary 
File 4). In general, cell cultures were fixed with 4% parafor-
maldehyde for 10–20 min at room temperature (RT), washed 
in PBS, permeabilized in 0.5% Triton X-100/PBS for 15 min 
at RT or in methanol for 10 minutes -20°C, washed with PBS, 
and blocked with 1% BSA/10% horse serum/PBS or with 
10% goat serum/PBS for 1 hour at RT. Primary antibodies used 
were: rat anti-MBP (MCA4095; 1:500); rat anti-CD45 (MCA 
1388; 1:300); rat anti-mouse CD68 (MCA1957T; 1:200; all 
Serotec Ltd, Oxford, UK), mouse anti-CNP (SMI191; 1:1000) 
and rat anti CD11b (Biolegend 101205 1:50; both Cambridge 
Bioscience, Cambridge, UK), SMI31 mouse antibody to phospho-
rylated neurofilament (1:1500; Affiniti Research Products Ltd., 
Derbyshire, UK), rabbit anti-Caspr (1:1000; kindly provided by 
Professor E. Peles), rabbit anti-green fluorescent protein (ab6556; 
1:1000; Abcam, Cambridge, UK), rat anti-lysosome-associated 
membrane glycoprotein 1 (1D4B; 1:2 Developmental Studies 
Hybridoma Bank, Iowa, U.S.A.), mouse anti-myelin oligodendro-
cyte glycoprotein, (1:200, clone Z2 provided by C. Linington), 
rabbit anti-ionized calcium binding adapter molecule 1 (Iba1; 
019-19741; 1:800, Wako, Neuss, Germany). These were diluted 
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in blocking buffer and incubations performed at RT for 1 
hour or overnight at 4°C. Anti-CD45 worked best on acetone 
fixed cells (10 mins, -20°C). Bound antibodies were visual-
ised using appropriate combinations of species/isotype-specific 
fluorochrome-conjugated secondary antibodies (1:400 [or in 
later experiments, 1:1000] 488 goat-anti mouse IgG1, catalogue 
number A2112; 568 goat anti-mouse IgG1, catalogue number 
A21124; 488 goat-anti-rat IgG, catalogue number A11006; 568 
goat anti-rat IgG, catalogue number A11077; 488 goat-anti rab-
bit IgG, catalogue number A11008; 568 goat anti-rabbit IgG, 
catalogue number A11036; all Alexa Fluor, Life Technologies) 
after incubation at RT for 15–60 minutes. Nuclei were stained 
with DAPI (2 μg/ml) for 5 minutes, then wells of the multi-well 
microplates were filled with 100 μl PBS (although Mowiol 
also works well, and solidifies). Coverslips were mounted on 
glass slides in Citifluor AF1 mounting medium (Agar Scientific, 
Essex, UK, catalogue number AGR1320) or Mowiol 4-88 pre-
pared as described in the supplementary protocol document, by 
dissolving 2.4 g Mowiol 4-88 (#81381, Sigma-Aldrich) in 6.0 g 
analytical grade glycerol, 6 ml distilled water, 12 ml 0.2 M 
Tris pH 8.5. Plates were imaged on an IN Cell Analyzer 2000 
(GE Healthcare) and coverslips were imaged using wide-field 
fluorescence microscopy.
Image Acquisition in Cell Analyzer
The IN Cell Analyzer 2000 (GE Healthcare) was used to acquire 
multiplexed wide-field fluorescent images in 96-well micro-
plate format with a Nikon 10X 0.45NA Plan Apo objective, with 
the following channels 490/20 nm & 525/36 nm (green), 579/24 
nm & 624/40 nm (red) and 350/50 nm & 455/50 nm (DAPI). 
Using these three channels, six fields of view were imaged 
per well. Flat Field Correction (illumination correction) was 
used as an image pre-processing step during image acquisition. 
Axonal density (area stained with antibody SMI31, anti- 
neurofilament), myelin (area stained with anti-MOG or anti-MBP) 
and cell counts (number DAPI +ve nuclei) were quantified 
using CellProfiler image analysis software version 2.1.0 
(Carpenter et al., 2006). The pipelines developed for this study 
are available from GitHub. A supplementary protocol document 
is attached (Supplementary File 5). Briefly, images were coded 
with parental metadata (imageID, wellID) and also with row/ 
column metadata. Quality control of the images was based on cell 
numbers, axon density and artefacts. Nuclei were identified in the 
DAPI image as primary objects after image thresholding using 
the Otsu global method. Shape was used to segment closely 
spaced cell. Images with less than 1500 nuclei/image were not 
used for subsequent analyses. Axonal density was measured 
in the red image (SMI31) after global thresholding using the 
Otsu, three classes weighted variance method. Total area occu-
pied by phosphorylated neurofilament was measured and image 
sets with less than 40% ‘axonal density’ were not used for sub-
sequent analyses. In the green channel (MBP), after applying an 
Otsu global threshold, myelin-like sheaths were identified using 
compactness ≥ 2.5 and form factor ≤ 0.2. Nuclei count, total 
area, axon area and myelin area measurements were exported to 
a comma-delimited spreadsheet for data analysis. The average 
value obtained from all images from each of the treatment con-
ditions, from a single independent cell culture, were considered 
one independent experimental unit, unless otherwise stated in the 
Figure legends.
Wide-field fluorescence microscopy
To quantify cellular parameters in myelin treated cultures, 10 
images (selected at random on the blue [DAPI] channel) each 
of the green (CD45), red (rhodamine-labelled myelin) and blue 
channels were captured using a x20 objective over two 13 mm 
cover slips per condition, for each independent experiment, using 
a CCD camera system (Photonic Science Colour Coolview) and 
ImagePro 6.0 software (Media Cybernatics, Silver Spring MD). 
To calculate CD45 +ve cell density, manual counts of CD45 
positive cells containing a DAPI-labelled nucleus were made 
from each image within an AOI of 124384 μm2 and the sum of 
the values were converted to cells per mm2. To quantify myelin 
uptake, the number of CD45 +ve cells containing rhodamine-
labelled myelin per AOI was expressed as a percentage of all 
CD45 +ve cells per AOI. The experimenter was blinded to the 
‘genotype’ of the myelin during cell quantification. Immunos-
tained cultures were also imaged on a Zeiss Axioimager M2 
wide-field microscope with Zen 2012 (Blue Edition) version 1.1.2.0 
software.
Cytokine arrays
Cytokine arrays were used to provide semi-quantitative data 
on cytokines and chemokines produced in response to dam-
age and pathogen associated molecular patterns. Cultures were 
incubated with cell culture grade PBS, myelin of either geno-
type in PBS (0.1 mg myelin-protein ml-1 final concentration), or 
LPS (100 ng ml-1; E-coli mutant O111:B4; VWR). One ml con-
ditioned media (CM) was collected at DIV 27, spun at 12470 g 
for 1 minute and the upper 800 μl was stored at -80°C until 
required. Semi-quantitative analysis of cytokine/chemokine levels 
was performed using Proteome ProfilerTM Array, Mouse Cytokine 
Array Panel A (ARY006; R&D Systems Europe Ltd., Abingdon, 
UK), according to manufacturer’s instructions. Briefly, nitrocel-
lulose membranes, containing 40 anti-cytokine antibodies in 
duplicate, were blocked in 2 ml of blocking buffer (array buffer 
6) on a rotating platform for one hour. CM from matched sam-
ples were probed in parallel. Eight hundred μl CM was added to 
0.5 ml of array buffer 4 and then adjusted to 1.5 ml with array 
buffer 5. Fifteen μl of reconstituted Cytokine Array Panel A 
detection antibody cocktail, containing biotinylated antibodies, 
was added to each CM sample, for 1 h RT. After removal of 
array buffer 6, the 4 nitrocellulose membranes (1 per condition) 
were incubated in the sample/antibody mixture overnight at 4°C. 
Membranes were incubated in 1.5 ml of streptavidin-HRP (in 
Array Buffer 5) for 30 m at RT then treated with Pierce enhanced 
chemiluminescence western blotting substrate catalogue number 
32106 (Perbio Science UK Ltd., Cramblington, UK) and 
subsequently exposed to x-ray film for between 1 and 20 min-
utes. X-ray films were scanned and made into digital images and 
the volume of each spot (minus the average edge volume) was 
quantified using array analysis software (TotalLab TL100 Array 
v2008; Newcastle upon Tyne, UK). For each membrane, the 
signal volume of each of two paired spots (representing a single 
cytokine) was normalised to the average spot volume of 6 posi-
tive control spots on the same membrane, and the average value 
of the paired spots, as a percentage of the control spot value, 
was derived. This method corrected for different incubations 
and/or exposures across different independent experiments. 
The experimenter was not blinded during this experiment or its 
analysis, but the automated quantification prevented experimenter 
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bias. Medium from each of the four conditions, from a single 
independent cell culture, was considered one experimental unit.
Electrophysiology
Dissociated E13 spinal cord cells were established on MEAs 
(60MEA200/30iR-Ti-gr; Multi Channel Systems, Reutlingen, 
Germany) as described in ‘Myelinating Cell Cultures’. Electro-
physiological recordings were performed from DIV 20-30. Sixteen 
channels were read simultaneously at 37°C in differentiation 
medium, in a custom-built laboratory MEA holder connected to 
a 16-channel amplifier (A-M Systems; Washington, USA). The 
array was subsequently rotated in the holder in order to read 
from all channels. Three minutes of extracellular recording 
were collected per channel (High Pass: 3 Hz; Low Pass: 500 Hz, 
Gain 20 k; Notch On). A semi-permeable membrane (fluorinated 
ethylene-propylene) was placed on top of the array, allowing 
cultures to be returned to the incubator and recordings to be 
made on subsequent days. Acquired data were analysed off-line. 
Modulators of neural activity were added directly to the bath: 
tetrodotoxin (TTX; 1 μM; Tocris Cat. 1069), cyanquixaline 
(CNQX; 5 μM; Tocris Cat. 1090), picrotoxin (100 μM, Sigma-
Aldrich, Cat. P1675).
For single cell recording, whole-cell current clamp recording 
was performed using an Axopatch 200B amplifier with a Digi-
data 1440A digital acquisition system and pClamp 10 software. 
Experiments were performed at 37°C in atmospheric CO2 using 
an extracellular solution containing identical ionic concentra-
tions to the cell culture media (in mM): 110.3 NaCl, 5.3 KCl, 
1.8 CaCl2, 0.8 MgCl2, 10 HEPES, 25 glucose, pH 7.4. The pipette 
solution contained (in mM): 135 K-gluconate, 2 MgCl2, 2 Na-
ATP, 0.5 Na-GTP, 10 HEPES, 0.5 EGTA, pH 7.2. Borosilicate 
glass pipettes were pulled to a resistance of 3-8 MΩ. TTX and 
other modulators (see above) were added directly to the tissue 
chamber.
Live imaging of myelin phagocytosis
Spinal cord cells were plated on 35 mm diameter glass bot-
tom Petri dishes (mentioned previously) and cultured for 20–22 
days. Immediately prior to imaging, rhodamine-labelled myelin 
was vortexed and added to the Petri dish at final concentration 
0.05 mg myelin-protein ml-1. The dish was set in a Nikon TE 
2000 time-lapse microscope inside a temperature/CO2-controlled 
chamber. Using Metamorph 7.5.2 imaging software set for 
multi-stage positions and multiple wavelengths, positions of inter-
est were selected on the bright field (phase), cherry (rhodamine) 
and CFP channels, and the co-ordinates recorded. Focus was set 
and maintained using a PSF perfect focus control. Images were 
taken every 15 minutes over a 15 h period. AVI videos of the 
stills collected were then generated using ImageJ 1.44 software.
Western blotting
Cell lysates from siRNA studies or spinal cord homogenates 
were prepared to 1 mg protein ml-1 in RIPA lysis buffer system 
with protease inhibitors (sc24948; Insight Biotechnology), plus 
5x loading buffer (Sodium dodecyl sulphate/Dithiothreitol dena-
turing buffer [SDS/DTT]), and heated to 65°C for ten minutes. 
Lysates (see Table 1 for protein amounts) were run on a 4–12% 
gradient NuPAGE bis-tris acrylamide gel (Invitrogen, Paisley, 
UK) at 200 volts for 40–50 minutes and transferred using a 
semi-dry system to a PVDF membrane (Millipore, Watford, 
UK) at 225 mA for 1 h per 2 gels. PVDF membranes were 
blocked in 5% milk in Tris-buffered saline/0.01% tween (TBS/T; 
pH 7.4) and incubated overnight with primary antibody (Table 1) 
in blocking solution at 4°C, with gentle agitation. Following 
thorough washing, membranes were incubated in horseradish 
peroxidase (HRP)-conjugated goat anti-mouse or goat anti-rabbit 
secondary antibodies (New England Biolabs, Dundee, UK) 
in blocking solution (Table 1) for 1 h RT. Following thorough 
washing and incubation in Pierce enhanced chemiluminescence 
western blotting substrate (Thermo Fisher Scientific, catalogue 
number 32106)), the PVDF membrane was exposed to x-ray film 
(AGFA) for 30 sec to 20 min to obtain optimal exposures.
siRNA
Dharmacon’s Accell siRNA passive delivery system including 
‘smart pool’ siRNA (Perbio Scientific) for “difficult to transfect 
cells” (Mir & Le Breton, 2008; Shen et al., 2008), was used. 
Qualitative assessment indicated that cultures incubated in Accell 
DM supplemented with biotin (10 ng/ml final) and D-glucose 
(4500 μg/ml final) (referred to as Accell DM+), fared better than 
cells incubated in Accell DM alone, therefore siRNA was rou-
tinely added to the cultures in DM+. At DIV 20, cultures were 
treated with (i) Accell DM+ (ii) 1 μM non-targeting (NT) siRNA, 
(iii) 1 μM CyB siRNA or (iv) 1 μM Cnp1 siRNA (all ‘smart pool’) 
in Accell DM+ for 72 hours between DIV 20-23 and for a further 
72 hours, between DIV 28-31. Between incubations with siRNA, 
cultures were fed as usual with differentiation media minus insu-
lin. Cell lysate from each of the five conditions, from a single 
independent cell culture, was considered one experimental unit.
Statistics
Statistical analyses were made using GraphPad Prism versions 
5.0, 6.0 or 7.0 for Windows (GraphPad Prism Software, San 
Diego, USA). Significance levels were set to p < 0.05. One-way 
ANOVA using Bonferroni’s Multiple Comparison Test was 
used to determine effects of siRNA, comparing all conditions 
to NT siRNA. For analysis of myelin uptake by CD45+ve cells 
between genotypes and across time points, a two-way ANOVA 
followed by Tukey’s multiple comparisons test was used. For 
analysis of steady state levels of 40 cytokines on proteome 
arrays, ‘multiple Student’s t tests’ were used to compare between 
myelin genotypes or between myelin genotype and PBS. Unless 
otherwise indicated, each n value derives from a single independ-
ent cell culture, comprising multiple wells or coverslips, repre-
senting technical replicates of the various treatments. In general, 
statistically tested experiments were carried out on 3–5 independ-
ent cell cultures, usually comprising 2 or more technical repeats 
(as indicated in Figure Legends or text). Up to 7 cultures per 
protein were examined by western blotting following treatment 
with siRNA, due to variation in the arbitrary units’ values from 
experiment to experiment.
Results
Spinal cord-derived cell cultures recapitulate functional 
properties of CNS white matter
The function and structure of CNS white matter is dependent on 
a complex interplay between axons, oligodendrocytes, astrocytes 
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and microglia; including physical, metabolic, receptor-dependent 
signaling and gap junction-mediated cell-to-cell communication. 
Myelinated cultures derived from E13 mouse spinal cord, reca-
pitulate this cellular complexity (Figure 1A–E), and by day in 
vitro (DIV) 24-28, comprise consecutive myelinated internodes 
separated by nodes of Ranvier (Figure 1F). To define this system 
in terms of function, we began by examining its electrical prop-
erties using microelectrode arrays (MEAs) (Figure 2A), each 
comprising 59 recording electrodes. The recordings obtained at 
a single electrode represent the combined extracellular responses 
of neurons and glia. Recordings taken daily between DIV 20 
and 24, when myelination is occurring, demonstrated the grad-
ual changes in electrical activity, starting with single isolated 
spikes and progressing to burst-like activity (Figure 2B). Addi-
tive pharmacology (sequential administration of drugs without 
washout) demonstrated distinct ‘network-like’ aspects of the 
neuronal activity (Figure 2C), not unlike the fictive bursting 
activity seen in isolated intact spinal cord segments (Grillner 
et al., 1981). Picrotoxin, a GABAergic inhibitor, evoked enhanced 
firing (second versus first trace) and subsequent addition of TTX 
(a voltage-gated Na+ channel blocker) blocked spike-like (pre-
sumably axonal) activity, whilst CNQX (blocker of AMPA/ 
kainate receptors) further blocked (presumably) excitatory post-
synaptic activity. The remaining slow potential changes (final 
trace) probably represent local spontaneous depolarizations at 
neuronal cell bodies and dendrites. To provide support for these 
conclusions we used single cell patch clamp recording. Spon-
taneous action potential generation was observed in 68 out 
of 75 cells tested; average spiking frequency being 2.13 ± 0.32 
Hz (mean ± s.e.m.). The firing frequency was highly variable 
between cells, ranging from 0.07 to 15.27 Hz. This activity could 
be enhanced with 100 μM picrotoxin (Figure 2D) or completely 
blocked by 1 μM TTX (Figure 2D). In summary, spinal cord 
myelinating cell cultures are electrically active and activity can be 
manipulated bi-directionally using pharmacology.
Next, we examined functional responses of microglia/macro-
phages, which were evident as IBA1 (Figure 1B) or CD45 +ve 
cells, at all stages examined from DIV 7-28. To assess the phago-
cytic capability of microglia/macrophages for a relevant target, 
we added increasing concentrations of rhodamine-labelled mye-
lin (subsequently referred to as ‘myelin debris’) on DIV 26 for 
24 h. The proportion of CD45 +ve cells incorporating myelin 
reached ~66% of cells at 0.075 or 0.1 mg myelin-protein ml-1. 
Internalized myelin appeared within lysosomal-associated mem-
brane glycoprotein 1 +ve structures, indicating its incorporation 
into late endosomes/lysosomes (Figure 3A). To assess conse-
quences of longer-term exposure to myelin debris, we incubated 
cultures for 1 or 7 days with myelin (0.1 mg myelin-protein ml-1) 
from wild type or Plp1 transgenic mice (Plp1 tg line #72; Readhead 
et al., 1994); the latter is a spontaneously demyelinating model 
of Pelizaeus Merzbacher disease (Anderson et al., 1999; Edgar 
et al., 2010) that like line #66 (Ip et al., 2006) is characterized 
by low-level T cell infiltration into the CNS (JE unpublished 
observations). The proportion of CD45 +ve cells containing myelin 
debris did not change significantly over time, or with the ‘geno-
type’ of the myelin (Figure 3B). To compare receptor-dependent 
versus independent phagocytosis (Sierra et al., 2013), we quanti-
fied the proportion of cells incorporating myelin versus latex beads; 
however the proportions were similar (Figure 3B).
In the resting brain in vivo, microglial soma are rather station-
ery but their processes are highly motile (Davalos et al., 2005; 
Nimmerjahn et al., 2005). In response to focal injury, or 
Table 1. Antibody and lysate details for western blots.
Supplier Cat. No. Host Approx. Mol 
weight
1° ab 2° ab Cell Lysate Spinal Cord 
Lysate
GAPDH Abcam Ab9845 Rabbit 40 kDa 1 in 1k 1 in 5k 5 μg 5 μg
CNP Cambridge Bioscience SMI-91R500 Mouse IgG1 46 and 48 kDa 1 in 5k 1 in 2k 20 μg 5 μg
β Actin Sigma-Aldrich A1978 Mouse IgG1 43kDa 1 in 1k 1 in 5k 5 μg 5 μg
226 (PLP 
/DM20)
N.P Groome Rabbit 27 kDa 1 in 50 k 1 in 5k 20 μg 2 μg
MAG 248 N.P Groome Rabbit 100 kDa 1 in 1k 1 in 5k 20 μg 5 μg
Mitofusin 2 Sigma-Aldrich M6319 Rabbit 86 kDa 1 in 1k 1 in 5k 20 μg 5 μg
OPA1 GeneTex GTX129917 Rabbit 112 kDa 1 in 1k 1 in 5k 20 μg
NF160 Sigma-Aldrich N2787 Mouse IgG1 160 kDa 1 in 100 k 1 in 10k 20 μg 2 μg
SMI31 Affiniti Research 
Products Ltd
SMI 31P Mouse IgG1 >200 kDa 1 in 100 k 1 in 10k 20 μg 2 μg
Parkin Santa Cruz sc-32282 Mouse IgG2b 52 kDa 1 in 500 1 in 5k 20 μg
Cyclophilin B Abcam ab178397 Rabbit 21kDa 1 in 1k 1 in 10k 5 μg 5 μg
Ac. tubulin Sigma-Aldrich T7451 Mouse IgG2b 55kDa 1 in 1k 1 in 10k 1 μg 5 μg
Ty. tubulin Sigma-Aldrich T9028 Mouse IgG3 55kDa 1 in 1k 1 in 10k 1 μg 5 μg
Page 8 of 27
F1000Research 2019, 8:117 Last updated: 21 MAR 2019
Figure 1. Embryonic day 13 mouse spinal cord cells differentiate over time into the major neural cell types of the nervous system. 
A. The morphology of CNP positive cells changes with time in culture. At 6 DIV, multiple cell process extend from the cell body and the cells 
have a ‘lacy’ appearance, as shown in the inset. By 12 DIV, a small number of myelin-like sheaths are present; often a single single sheath 
can be observed running in a line through one axis of an otherwise ‘lacy–appearing’ cell. In the inset, two such sheaths can be observed 
along 3 adjacent ‘lacy-appearing’ cells. By 21 DIV, many cells have extended multiple myelin-like sheaths and by 28 DIV few ‘lacy-appearing’ 
cells remain and a dense network of myelin sheaths are visible. When stained with antibodies to PLP/DM20, Caspr and phosphorylated 
neurofilament (NF), many axons are covered by consecutive sheaths with nodes of Ranvier straddled by Caspr positive paranodes (bottom 
right image). B. Iba1 +ve microglia are present at all stages examined. At 7DIV most microglia appear amoeboid but become ramified and 
extend multiple processes over time (insets). C. Antibody to NeuN labels neuronal nuclei and sometimes staining extends into the cytoplasm, 
but rarely enters the cell processes. D. GFAP positive astrocytes are found throughout the culture, (E) as are NG2 +ve OPCs. F. Combined 
staining with antibodies to PLP/DM20, Caspr and phosphorylated neurofilament (NF), reveals that many axons are covered by consecutive 
sheaths with nodes of Ranvier straddled by Caspr positive paranodes. Images A–F were contrast enhanced to ease viewing.
simulation of injury by local application of ATP, cell soma 
(Honda et al., 2001) or processes independent of the cell soma 
(Davalos et al., 2005), converge on the injury site. To assess 
the dynamic behavior of phagocytic microglia/macrophages in 
spinal cord-derived cultures, we used live imaging immedi-
ately following the addition of rhodamine-labeled myelin debris. 
Cells identified as microglia/macrophages on the basis of their 
incorporation of myelin debris, were motile with respect to both 
the soma and processes, appearing to ‘gather’ myelin debris for 
ingestion. Qualitatively, the vast majority of exogenous myelin 
was internalized within the 15 h imaging period (Figure 3C and 
Supplementary Video 1).
In vivo, microglia not only express receptors that mediate phago-
cytosis of cellular debris, but also initiate responses to pathogen-
associated molecular patterns (PAMPs) such as endotoxins and 
viral nucleic acids, and damage-associated molecular patterns 
(DAMPS) such as high mobility group box 1 (HMGB1) and 
ATP. To examine the secretory profile of spinal cord-derived 
cultures challenged with (i) lipopolysaccharide (LPS; from Gram-
negative bacteria; 100 ng ml-1 final) or (ii) myelin debris (0.05 
mg myelin-protein ml-1 final), we used a commercially avail-
able proteome array for the unbiased detection of 40 cytokines/
chemokines. In preparing myelin debris, we took care to 
minimize the risk of contamination by endotoxin, by using cell- 
culture grade plastics and media wherever possible. As expected, 
LPS led to a significant increase in steady state levels of pro- 
inflammatory cytokines, TNFα, IL1-α, IL-6 (all p < 0.001), IL1β 
(p < 0.01); anti-inflammatory cytokine IL1-ra (p < 0.01); granu-
locyte colony stimulating factor (G-CSF; p < 0.001); chemok-
ines CCL1, CCL3, CCL4, CCL5, CCL12, CXCL1, CXCL2, 
CXCL10 (all p < 0.001), CXCL9 (p < 0.05); soluble intracellular 
adhesion molecule 1 (sICAM1; p < 0.001) and TIMP 
Metallopeptidase Inhibitor 1 (TIMP1; p < 0.001), compared to PBS 
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Figure 2. Myelinating cell cultures are spontaneously electrically active. A. Low power view of the whole MEA (left); all 59 recording 
electrodes and the ground electrode are concentrated in the center of the array. In the high-power image (right), four electrodes (black 
circles) can be observed in relation to the cell bodies (white arrows) and processes (including axons; blue arrowheads) of neurons and 
glia, on an MEA. To facilitate viewing, we selected a region in which cell density is lower than normal. Extracellular activity can be assessed 
from each of 59 recording electrodes. B. Extracellular recordings from a single electrode between 20 and 24. DIV. Each trace represents 
the sum of the activity detected at that electrode, which is in direct contact with multiple neuronal and glial cell bodies and processes. ‘Fast’ 
spike-like activity is evident at DIV 21 and ‘burst-like’ activity develops by DIV 24. C. Additive pharmacology on a DIV 24 culture (sequential 
administration of drugs without washout) demonstrates in vivo-like neuronal network activity of spinal cord myelinating cultures. The recording 
shows that addition of picrotoxin, a GABAergic inhibitor, evokes a massive increase in ‘fast’ neuronal activity (second versus first trace). 
Subsequent addition of TTX (a Na+ channel blocker) inhibits much of the ‘fast’ spike-like (presumably axonal) activity. CNQX (a blocker of 
AMPA/kainate receptors) blocks excitatory synaptic activity. The remaining slow potential changes probably represent local spontaneous 
depolarizations (at neuronal and glial cell bodies). D. Examples of whole-cell current clamp recordings from single cells, presumably neurons, 
firing spontaneously at a resting potential of around -50 mV. Top, trace before and 5 minutes after the addition of 1 μM TTX (top). Bottom, 
trace from a second cell before and 5 minutes after the addition of 100 μM picrotoxin. TTX consistently blocked activity (n = 6 cells), as 
expected, whilst picrotoxin caused regular burst spiking in every cell tested (n = 18 cells), but the effect on overall spike rate was inconsistent, 
presumably reflecting the phenotype of the cell.
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Figure 3. Motile microglia/macrophages take up myelin debris in vitro. (A) ID4B antibody staining of cultures treated with rhodamine-
labelled myelin debris at 27 DIV shows myelin debris (red) within lysosomal associated membrane glycoprotein 1 (green) late endosomes/
lysosomes. All cells containing myelin were found to be CD45 +ve (not shown). (B) After incubation with saturating amounts of myelin debris 
(data obtained with 0.075 or 0.1 mg myelin protein ml-1 were similar, so values from each were included providing two technical replicates) 
over three different time periods, the percentage of CD45 positive cells that contained ‘wild type’ (pale grey bars) or Plp1-tg (dark grey 
bars) myelin debris, which is taken up in a receptor-dependent manner, was between 40–70 % (n = 6; 2 technical replicates for each of 3 
independent experiments, per time point); not significantly different from the proportion that contained latex beads (black bar), which are 
taken up in a receptor-independent manner (n = 3 independent experiments). Bars represent mean +/- s.e.m.. (C) Time lapse stills over 1130 
minutes show myelin debris (red) at time of addition (25 mins – 275mins) and then being phagocytosed by microglia/macrophages (440 mins 
– 1130 mins). Blue and green arrows highlight the locations of individual cells over time.
Page 11 of 27
F1000Research 2019, 8:117 Last updated: 21 MAR 2019
(n = 3-4 replicates from 2-3 independent cultures). A representa-
tive proteome array is shown in Figure 4A. In contrast, exposure 
of the cultures to myelin debris resulted in a much more restricted 
response, lacking upregulation of pro-inflammatory cytokines. 
However, chemokines CCL3 and CCL4 were significantly 
upregulated in cultures treated with either wild type or Plp1 tg 
myelin, compared to vehicle-treated controls (PBS; Figure 4B 
and C), as were TIMP1 and M-CSF (p < 0.001–0.05; n = 3 inde-
pendent cell cultures and 6 independent myelin preparations 
[3 WT and 3 Plp1 tg]). Notably however, compared to wild 
type myelin debris, Plp1 tg myelin debris was associated with 
significantly increased steady state levels of CXCL1, CXCL2, 
CXCL10 and CCL5 (Figure 4B and C), the last two of which 
are strongly linked to T cell infiltration into the CNS (reviewed 
Hughes & Nibbs, 2018).
Together, these data demonstrate that innate immune cell prop-
erties, including phagocytosis of tissue debris and appropriate 
cytokine secretion profiles are reproduced in pure spinal cord- 
derived myelinated cultures.
Gene expression can be knocked-down in myelinating cell 
cultures using siRNA
Having established these cultures recapitulate relevant in vivo 
functions, we next asked if they are amenable to manipulation 
using siRNA and thus capable of being used as a screen for 
gene silencing approaches. We selected 2’, 3’-cyclic nucleotide 
3’-phosphodiesterase (CNP), which is expressed early in the 
oligodendroglial lineage and eventually localized to the cell 
soma, processes and non-compact myelin (Trapp et al., 1988). 
We began by defining the temporal sequence of CNP expres-
sion using immunocytochemistry. We observed a small number 
of CNP +ve cell bodies as early as DIV 2, and by DIV 4, CNP 
was also observed in short cellular processes (data not pro-
vided). By DIV 6, multiple ‘lacy-appearing’ CNP +ve cells 
were visible (Figure 1A) and by DIV 12, occasional myelin-like 
profiles were present; often as a single myelin-like sheath 
extending from an otherwise ‘lacy-appearing’ cell (Figure 1A). 
Myelin-like profiles increased in number and extent with time, and 
the number of ‘lacy-appearing’ cells correspondingly diminished 
(Figure 1A).
To deplete Cnp1 mRNA, cultures were incubated intermittently 
with siRNA from DIV 20, when CNP was already expressed 
(Figure 1A and Figure 5A), until DIV 31. CyB siRNA was used 
as a positive control. By western blot, steady-state levels of CNP 
or cyclophilin B were significantly reduced by their respective 
siRNAs, compared to non-targeting (NT) siRNA-treated controls 
(Figure 5A and B). In contrast, steady-state levels of proteoli-
pid protein (PLP), myelin associated glycoprotein (MAG), actin, 
cyclophilin B or phosphorylated neurofilament heavy chain 
(Ph NF-H), were not altered in CyB or Cnp1 siRNA-treated 
cultures compared to NT siRNA controls. With the exception of 
MAG, levels of all proteins were similar in NT siRNA-treated 
cultures compared to cultures treated only with Accell DM+ 
incubation medium (Figure 5A and B). Qualitatively, 
neurofilament medium chain (NF-M), acetylated tubulin, tyro-
sinated tubulin (Figure 5A) and mitochondrial-related proteins, 
OPA1, mitofusin and parkin (data not in the manuscript, but 
attached in raw data files, Exps N10, 12, 13, 23, 24 and 30, 
Dataset 1, (Bijland et al., 2019)) were also not obviously changed 
under any treatment conditions, suggesting siRNA is not toxic 
to these cell cultures, even after relatively long incubation times. 
Using immunocytochemistry with antibodies to CNP (in non-
compact myelin), GFP (to stain CFP +ve neurones from the 
Thy1-CFP mouse embryos) and myelin basic protein (MBP; in 
compact myelin), CNP specifically appeared reduced in cell bod-
ies and myelin sheaths in Cnp1 siRNA-treated cultures compared 
to DM+ only or CyB siRNA-treated controls (Figure 5C and D).
In summary, this myelinating cell culture system is amenable 
to siRNA gene expression knockdown, in the absence of overt 
off-target effects.
Myelinating cultures can be adapted to a semi-high 
throughput format
We have previously used this culture system to identify factors 
that influence myelination, however to increase its utility in 
this respect we asked if it could be adapted it to a format that 
would allow semi-high throughput screening of multiple factors, 
simultaneously.
Empirically, we have observed that poly-L-lysine in boric acid 
buffer is a highly effective substrate for cell adhesion, therefore 
96-well microplates were prepared accordingly, and E13 mouse 
spinal cord cells were plated at a density of 75,000, 85,000 
or 100,000 cells/well. Using immunocytochemisty to label 
myelin sheaths (anti-MBP), axons (SMI31, anti-phosphorylated 
NF-H) and oligodendroglia (anti-Olig 2), we found that a starting 
density of 100,000 cells/well led to a reproducible generation of 
myelinated axons after 24 DIV (data not shown). Qualitatively, 
plating densities of <100,000, led to lower levels of neuritic 
outgrowth and myelination.
As most small molecule libraries are diluted in DMSO, we checked 
if DMSO adversely affected the cultures. Growing the cells in the 
presence of 1% DMSO had no significant effect on axon density 
or myelination (mean difference 2.4 % for axon density, mean 
difference 0.4 % for myelin, (see raw data files pertaining to 
Figure 6 and Figure 7, Dataset 1, (Bijland et al., 2019)).
Next, we established a protocol for automated image capture 
using the IN Cell Analyzer 2000 High Content Screening micro-
scope (GE Healthcare), and an automated image quantification 
method using CellProfiler (Carpenter et al., 2006). Our 
analysis protocol quantified nuclear number, phosphorylated neu-
rofilament (axonal) area and PLLS (power log-log slope, as an 
indicator of amount of blur in the image) and excluded images 
with nuclei numbers < 1500, axon area < 40% or PLLS > -2.0. 
For each image that passed quality control, the area occupied 
by myelin-like sheaths (stained with anti-MBP) and the area 
occupied by phosphorylated neurofilament (stained with anti-
body SMI31) were quantified, and MBP area expressed as 
a proportion of neurofilament area.
To test if our automated image capture and quantification proto-
cols were sufficiently robust to detect changes in myelination, we 
treated myelinating cultures from day 19 with FGF9, a known 
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Figure 4. Spinal cord cultures mount appropriate responses to diverse stimuli. A. Map of proteome arrays shows six positive control 
(A1,2; A23,24; F1,2) and two negative control (F23,24) spots, alongside 40 paired cytokine-specific spots (B1,2-E7,8). The array on the right 
was incubated with medium from cultures treated with LPS. A number of cytokines and chemokines (highlighted with white boxes), including 
pro-inflammatory cytokines, were upregulated in LPS-treated cultures compared to PBS-treated controls. Quantification is provided in the 
text. B. Proteome arrays incubated with medium from cultures treated with a myelin-enriched tissue fraction from wild type or a spontaneously 
demyelinating model of Pelizaeus Merzbacher disease (Plp1 tg myelin) for 1 or 7 days. After 7 days, two chemokines were upregulated in 
cultures treated with wild type or Plp1 tg myelin compared to PBS-treated cultures (highlighted with boxes with broken lines). An additional 
four chemokines were upregulated specifically in Plp1 tg myelin-treated cultures compared to wild type myelin-treated cultures (highlighted 
with boxes with solid lines). C. Graph of chemokines upregulated in cultures treated with myelin-enriched tissue preparations for 7 days. 
Bars represent mean +/- s.e.m. n = 3 independent cultures to which 6 independent myelin preparations were added (1 preparation per 
independent experiment from wild type mice and 1 preparation per independent experiment from Plp1 transgenic mice). Each cell culture 
(considered n = 1 independent biological repeat) comprises up to 24 × 35 mm dishes each containing 3 coverslips coated with cells. Eight 
35 mm dishes are contained within one 25 mm diameter dish. Wild type or Plp1 transgenic myelin were added to two 35 mm dishes, from 
within one larger 25 mm diameter dish. There was no systematic selection process for deciding which dishes would receive wild type versus 
Plp1 transgenic myelin, as all dishes were identical. Raw data files attached. * p < 0.05, ** p < 0.01, *** p < 0.001.
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Figure 5. Spinal cord cultures are amenable to gene knockdown using siRNA. A. Western blots of (from L to R) spinal cord lysates from 
wild type and Cnp1 knockout (ko) mice and cell lysates from DIV 30 spinal cord cultures following treatment with supplemented incubation 
medium only (DM+), Cnp1 siRNA, CyB siRNA or non-targeting (NT) siRNA. Lysates from time 0 (DIV 20) cultures, were run alongside. 
B. Quantification myelin proteins, housekeeping proteins and axonal proteins in siRNA treated cultures. Bars represent mean +/- s.e.m. 
Values were obtained from n = 4–7 independent cultures. Seven independent experiments were undertaken but some proteins were only 
examined in 4, 5 or 6 of these as shown in the attached raw data files. All 7 experiments were probed for CNP and 6 of 7 were probed for 
cyclophilin B, against which the siRNA was designed. * p < 0.05, ** p < 0.01. C. Micrographs of cultures prepared from Thy1-CFP mouse 
embryos, treated with DM+, CyB siRNA or Cnp1 siRNA, and stained with anti-GFP (binds CFP which is expressed in a subset of neurons) 
and anti CNP. White arrows point to CNP +ve oligodendrocyte cell bodies or CFP +ve neuronal cell bodies. The punctate ‘staining’ indicated 
with broken yellow arrows represents autofluorescent lipofuscin granules, which are prevalent in these cultures. CNP is markedly reduced in 
Cnp1 siRNA-treated cultures. D. Micrographs of cultures treated with DM+, CyB siRNA or Cnp1 siRNA, and stained with anti-MBP (MBP is 
located in compact myelin) and anti-CNP (CNP is located in non-compact myelin). CNP is markedly reduced in Cnp1 siRNA-treated cultures, 
but MBP appears unchanged.
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Figure 6. Spinal cord cultures grown in 96-well microplates are amenable to modulators of myelination. A. Representative 
immunofluorescence images of 96-well microplate myelinating cultures (28 DIV) stained for MBP, phosphorylated neurofilament (SMI31) 
and nuclei (DAPI). Cells were untreated or treated with Activin-A or FGF9 as described. B. Percentage change in myelination, axon density 
and nuclei count after treatment with Activin-A or FGF9. Bars represent average values from 5 independent cultures, each with 5 wells of 
technical replicates (wells), +/- s.e.m.. Raw data attached. Cells were allocated to different treatments as described in Materials and Methods. 
* p < 0.05, **p < 0.001.
mitogen and inhibitor of myelination (Lindner et al., 2015), or 
from day 15 with activin A, a known enhancer of myelination 
(Goebbels et al., 2017; Miron et al., 2013) until DIV 28. FGF9 
induced a significant (-31.7%, p < 0.05) decrease in myelination 
while activin A (100 ng ml-1) produced a significant (+56.5 %, 
p < 0.001) increase in myelination, relative to vehicle-treated 
cultures (Figure 6). Furthermore, FGF9 (100 ng ml-1) led to a 
significant (+53,8 %, p < 0.001) increase in nuclear density (aver-
age of 5 independent experiments; each with 5 technical repeats), 
as expected for a pro-proliferative factor (Lindner et al., 2015). 
To test the sensitivity of our assay, we treated cultures with 
1, 5, 10, 50 or 100 ng ml-1 activin A and found that increasing 
concentrations (1-100 ng/ml) of activin A led to a dose-depend-
ent increase in the degree of myelination (Figure 7; average of 2 
independent experiments; each with 5 technical repeats).
Thus, the methods are robust and sufficiently sensitive to detect 
small changes in myelination and cell densities.
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Figure 7. Microplate assays are sensitive to small changes in myelination. Spnal cord cultures were treated with increasing doses 
of Activin-A. A. Representative immunofluorescence images of 96-well microplate myelinating cultures (28 DIV) stained for MBP and 
phosphorylated neurofilament (SMI31). B. Dose-response curve for myelination in response to Activin-A treatment. Average values from 2 
independent cultures, 5 technical repeats per culture, +/- s.e.m.
Page 16 of 27
F1000Research 2019, 8:117 Last updated: 21 MAR 2019
As libraries of small molecules are costly, we proceeded to test 
whether myelinating cultures could be grown in 384-well micro-
plates, which would allow markedly smaller amounts of com-
pounds to be used in each assay. We plated spinal cord cells at 
densities of 30,000, 40,000 or 50,000 cells/well and stained the 
cultures with antibodies to phosphorylated neurofilament and 
MBP. Qualitatively, we found that the optimal plating density was 
50,000 cells/well but the cultures tended to be less reproducible 
in this format.
Dataset 1. An in vitro model for studying CNS white matter: 
functional properties and experimental approaches
https://dx.doi.org/10.5256/f1000research.16802.d233269
Discussion
Here we demonstrated that a murine, pure spinal cord-derived 
cell culture system (Thomson et al., 2006; Thomson et al., 2008) 
recapitulates several in vivo cellular functions, namely, spon-
taneous spinal-like electrical activity; phagocytosis of tissue 
debris; and appropriate secretory responses to diverse stimuli. 
Further, the system, which is straightforward to establish, can be 
used to assay gene-silencing approaches; adapted to a 96-well 
format for semi-high throughput assays of multiple factors simul-
taneously; or for growth on MEAs to monitor electrical proper-
ties. These advances increase the utility of this system for studies 
to address white matter development, function and pathology, 
providing the research community with a robust experimental 
tool that reduces costs and minimises the use of experimental 
animals. In particular, the multi-well format allows large 
numbers of factors to be assayed in parallel, whilst simultaneously 
reducing the numbers of mice required to provide tissue.
Whilst this in vitro model of CNS white matter is not intended to 
replace all animal work, it can inform, or augment such experi-
ments. For example, we previously identified pro-myelinating 
factors from a list of candidates generated from transcriptomic 
analyses of laser-captured CNS tissue from Pten conditional 
knockout and control mice, using 11 independent cell cultures 
(Supplementary Figure 8 h; Goebbels et al., 2017) from 11 preg-
nant dams. A similar in vivo experiment would first require inva-
sive surgery to administer a demyelinating agent into the CNS, 
followed by subsequent administration of the pro-myelinating 
compounds by the same route. Given that 8 compounds were 
analysed (Goebbels et al., 2017), a similar in vivo study would 
require the same 8 compounds to be administered to a least 
11 mice per treatment group, assuming variation similar to that 
observed in cell culture; requiring at least 88 experimental animals. 
In this instance, our in vitro model affords an 87.5% reduction 
in the number of animals required compared to a similar in vivo 
experiment.
Microelectrode arrays increase the utility of spinal cord 
cultures
In CNS white matter, a supra-threshold axon caliber is necessary 
for initiation of myelination (Mayoral et al., 2018) and, when 
experimentally induced, is associated with de novo myelina-
tion of axons that ordinarily, are not myelinated (Goebbels et al., 
2017). Myelin formation is further modulated by neuronal 
signals, including activity-dependent signals (Gibson et al., 
2014; Hines et al., 2015; Mensch et al., 2015; Mitew et al., 
2018). In neurons themselves, action potential firing patterns 
modulate the abundance of neuronal mRNAs across many func-
tional gene categories affecting, for example, neurite outgrowth, 
synaptic connections and neural network formation (Lee et al., 
2017), whilst conversely, protein levels can modulate neuro-
nal activity (Lopez de Armentia et al., 2007). Thus, the circular 
relationship between fast electrical responses and longer-term 
changes in gene expression is important for nervous system devel-
opment and plasticity (Lee et al., 2017). Here we demonstrated 
that spinal cord-derived myelinating cultures are spontaneously 
electrically active, and likely subject to similar bidirectional 
regulation of gene expression in neurons and in oligodendrocytes.
Neural electrical activity readouts provide information on fac-
tors such as cell phenotype, metabolic status and health. As few 
laboratories are equipped with the necessary equipment and 
expertise to perform intracellular recordings, we reasoned that 
commercial MEAs might provide an accessible method for 
assaying global extracellular electrical responses. Using MEAs 
we identified fast spike-like, low amplitude extracellular activity 
that increased in frequency in the presence of the GABA recep-
tor antagonist, picrotoxin, suggesting that inhibitory neurons 
suppress this spontaneous activity. Conversely, spike-like activ-
ity was reduced by the voltage-gated sodium channel blocker, 
TTX, indicating it represents axonal action potentials. The AMPA 
receptor antagonist, CNQX, blocked some of the TTX-resistant 
activity, suggesting it represents changes at dendrites brought 
about by the synaptic release of glutamate. This is compatible 
with ultrastructural observations in these cultures (Figures 6F 
and G; Thomson et al., 2008). To validate these MEA data, we 
used single cell current clamp recording which confirmed that 
high frequency action potential activity was present and could 
be enhanced by picrotoxin, or blocked by TTX (Figure 2) or 
CNQX (raw data provided separately, Dataset 1, (Bijland et al., 
2019)); the last demonstrating it is glutamate-dependent. 
However, it is important to bear in mind that the extracellular 
activity recorded on the MEAs represents the sum of all neuronal 
and glial electrical responses at the recording electrode. 
In terms of ease of use, spinal cord cells adhered well to MEAs 
and appeared, under phase contrast microscopy, indistinguish-
able from cells grown on glass. MEAs do not require the same 
specialist expertise or equipment needed for intracellular record-
ings and have the advantage that electrical activity can be 
assessed sequentially over days or even weeks. Further, they 
provide an overview of activity that cannot be achieved easily 
using intracellular recordings. Consequently, MEAs increase the 
utility of this multi-cell type culture for studies such as ion channel 
screening, drug testing and safety pharmacology.
Spinal cord-derived cultures mount appropriate responses 
to diverse stimuli
In response to infectious, autoimmune or physical insults, micro-
glia mount neuroinflammatory responses to combat pathogens 
and enhance repair and restoration of function (reviewed in 
Song & Colonna, 2018b; Song & Colonna, 2018a). However, 
this response must be finely balanced as excessive or chronic 
neuroinflammation can, in some circumstances, contribute to 
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disease pathogenesis (Song & Colonna, 2018b; Song & Colonna, 
2018a; Song et al., 2017). Pattern recognition receptors (PRRs) 
on microglia play a major role in the initiation of these responses. 
Originally discovered for their role in recognizing pathogen-
derived molecular signatures, PRRs also respond to damage 
associated molecular patterns (DAMPs) released by dying or 
damaged cells, such as ATP, high mobility group box 1 protein 
(HMGB1), beta amyloid and α-synuclein (Kigerl et al., 2014). 
Chronic generation of DAMPs within the CNS can therefore 
run the risk of causing secondary, collateral tissue damage by 
sustaining long-term activation of pro-inflammatory responses 
(reviewed in Song et al., 2017).
To determine if spinal cord-derived cultures respond appropriately 
to a classical PAMP, we challenged them with bacterial lipopoly-
saccharide (LPS) and compared their response to that induced by 
myelin debris; sterile clearance of which is essential to promote 
lesion repair in demyelinating diseases such as MS and experi-
mental models (Kotter et al., 2005; Napoli & Neumann, 2009; 
Neumann et al., 2009) in a CX3CR1-and TREM2-dependent man-
ner (Cantoni et al., 2015; Lampron et al., 2015; Poliani et al., 
2015). LPS is a well-characterized PAMP that activates toll-like 
receptor 4 (TLR4) to up-regulate expression of pro-inflammatory 
cytokines and chemokines by a wide variety of immune cells 
(Chow et al., 1999).
As the resident immunocompetent population of the CNS, 
microglia express multiple toll-like receptors, including TLR4 
(Bsibsi et al., 2002; Zhang et al., 2014) and initiate inflamma-
tion in response to PAMPs by secreting pro-inflammatory factors. 
These include cytokines such as tumor necrosis factor (TNF)-α, 
interleukin (IL)-1β, and IL-6 and free radicals such as nitric 
oxide (NO) (Hanisch & Kettenmann, 2007; Hines et al., 2013; 
Tambuyzer et al., 2009). This was replicated in spinal cord 
myelinated cultures, in which LPS increased secretion of pro- 
inflammatory cytokines (IL-1α, Il1β, IL-6 and TNFα), as well 
as CCL and CXCL chemokines, mimicking the CNS response 
induced by viruses, bacteria or parasites (Forrester et al., 2018; 
Lobo-Silva et al., 2016). In striking contrast, clearance of ‘wild 
type’ myelin debris in these cultures did not induce an overt pro-
inflammatory response, but selectively increased secretion of 
CCL and CXCL chemokines. This is in agreement with the homeo-
static roles of microglia (and astrocytes) associated with clearance 
of myelin and other cellular debris injury (Perry et al., 1985). 
Conspicuously however, challenging cultures with Plp1-tg mye-
lin resulted in additional up regulation of CCL5 and CXCL10. 
Whilst chemokines facilitate context-dependent migration of all 
immune cells, CCL5 and CXCL10 and their receptors are par-
ticularly relevant with respect to T cell recruitment into the brain 
(Hughes & Nibbs, 2018). These observations are especially 
interesting in light of the fact that increased numbers of T lym-
phocytes are present in the CNS of spontaneously demyelinating 
Plp1 tg mouse models of Pelizaeus Merzbacher disease (PMD), 
caused by gene duplication (JE, unpublished observations 
and Ip et al., 2006). CXCL10 expression is induced by type I 
interferons to recruit T lymphocytes into the CNS to protect 
against neurotropic viral infections (Liu et al., 2000) and it and 
its receptor, CXCR3, are necessary for induction of experimental 
cerebral malaria (ECM); probably due to the critical role CXCL10 
plays in T cell-endothelial cell adhesion, and injury of the brain 
endothelium (Sorensen et al., 2018). Further, the increased 
susceptibility to encephalitic symptoms after infection with 
West Nile virus, of individuals harbouring mutated CCR5, which 
encode the receptor for CCL5, is thought to be due to failure 
of trafficking of T cells into the brain (Glass et al., 2005) and 
reviewed in (Hughes & Nibbs, 2018). The molecular basis for 
the difference in chemokine induction between the two myelin 
‘genotypes’ is not known; although our working hypothesis is 
that myelin isolated from Plp1 tg mice is subtly altered allowing 
it to cross-link or activate additional receptors at the microglial 
surface (Lennartz & Drake, 2018).
The importance of replicating the multi-cell type environment 
of the CNS when studying microglial functions such as these is 
highlighted by the fact that microglial phenotypes are modulated 
by neighboring cells and vice versa. For example, LPS-induced 
secretion of IL-1β and TNF by microglia can result in potent 
induction of pro-inflammatory gene expression by astrocytes in 
vitro (reviewed in Saijo & Glass, 2011), whilst signaling induced 
by microglial CD172, CD200R and CD45 interacting with CD47, 
CD200 and CD22, respectively at the neuronal cell surface, 
inhibits microglial activation (reviewed in Saijo & Glass, 2011).
Spinal cord cultures can be used to test gene-silencing 
strategies
Neurodegenerative diseases, including those that predomi-
nantly affect white matter, such as the leukodystrophies and 
amyotrophic lateral sclerosis (ALS) remain largely untreatable 
or relatively refractory to currently available therapies. In both 
cases, a dominant gain-of-function effect of the protein products 
of mutated genes contribute to pathogenesis in some forms of 
these diseases, for example in familial amyotrophic lateral scle-
rosis (fALS) due to mutation in SOD1 gene and in Pelizaeus 
Merzbacher disease (PMD) due to point mutation or duplication 
of the PLP1 gene (reviewed in van Zundert & Brown Jr., 2017; 
Nave & Griffiths, 2004). Thus, gene silencing using siRNA or 
antisense oligonucleotides represents a rational approach to treat-
ment that is potentially devoid of some of the problems caused 
by the broad modes of actions of small molecule-based drugs 
(Zheng et al., 2018). A number of issues related to the systemic 
administration of siRNA or antisense oligonucleotides for CNS 
disorders remain to be overcome, such as delivery in the blood 
circulation, passage across the blood-brain barrier, and target-
ing to the appropriate cell type (Zheng et al., 2018). Nonethe-
less, it is important to have relevant in vitro models to carry out 
preliminary tests of the efficiency of gene knockdown and to 
screen for off-target effects before proceeding to in vivo studies. 
This is particularly important for genes expressed in post- 
myelination oligodendrocytes; cells whose phenotype is altered 
when they wrap axons.
Spinal cord cultures are amenable to use in semi-high 
throughput assays
Unlike PMD and fALS, which are genetically determined, MS is 
an acquired inflammatory demyelinating disease, affecting more 
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than 2 million people worldwide (World Health Organization, 
2008). MS involves a neurodegenerative process driven in part 
by the failure of MS lesions to remyelinate (Franklin & Ffrench- 
Constant, 2008; Franklin et al., 2012; Trapp & Nave, 2008). 
Consequently, a potential therapeutic approach is to stimulate 
remyelination; an effect that enhances functional recovery 
(Duncan et al., 2009) and is predicted to reduce ongoing axonal 
loss (Irvine & Blakemore, 2008; Mei et al., 2016). Spontane-
ous remyelination in MS is incomplete, leaving many axons 
chronically devoid of myelin (Patani et al., 2007). This is thought 
to render them vulnerable to inflammatory insult and devoid of 
oligodendroglial-mediated support (Franklin et al., 2012; Nave & 
Trapp, 2008; Trapp & Nave, 2008). In the adult brain, new mye-
lin sheaths are formed by OPCs (Crawford et al., 2016; Keirstead 
& Blakemore, 1997; Zawadzka et al., 2010), which are often 
abundant in MS lesions but fail to myelinate the naked axons 
(Chang et al., 2000; Chang et al., 2002; Scolding et al., 1998). 
Recent studies are beginning to identify drugs, small molecules 
and pathways that can be modulated to overcome remyelina-
tion failure. These include Wnt/β-catenin (Fancy et al., 2009), 
retinoid X receptor gamma (RXRγ) signalling (Huang et al., 
2011), muscarinic receptor antagonists such as benztropine and 
clemastine (Deshmukh et al., 2013; Mei et al., 2014) activin A 
(Goebbels et al., 2017; Miron et al., 2013) and drugs includ-
ing miconazole and clobetasol (Najm et al., 2015). However, 
there is still a need for a cost-effective screening strategy to 
identify molecules with therapeutic potential for the treatment 
of MS and other multifactorial neurodegenerative disorders.
A valuable pre-in vivo screen of candidate therapeutics should 
fulfil certain criteria. First, it should contain all major cell types 
of the CNS, to resolve off-target effects of the test agent. Sec-
ond, it should be simple to establish, reproducible, sensitive 
and unbiased. Third, it should be unaffected by carriers such as 
DMSO. Fourth, it should be capable of screening a substantial 
number of agents while using the minimum number of experi-
mental animals. Finally, it will provide added-value if it can be 
generated from mouse models of disease and/or transgenic reporter 
mice for live imaging or expression analysis. Here we demon-
strated murine spinal cord-derived cultures meet these criteria 
for semi-high throughput screens and recapitulate relevant func-
tional properties of CNS white matter. Given the ease with which 
they can be established, this system provides laboratories with a 
simple, functional and relatively inexpensive method to explore 
normal and pathological processes relevant to white matter 
in general, and spinal cord in particular.
Data availability
Underlying data is available from F1000Research
F1000Research: Dataset 1. An in vitro model for studying CNS 
white matter: functional properties and experimental approaches, 
https://doi.org/10.5256/f1000research.16802.d233269 (Bijland et 
al., 2019)
Data is available as a zip file contain the corresponding data for 
the following figures:
Figure 1- Raw microscope image files
Figure 2B, C and D and for CNQX treated cell (not shown in 
Figure 2) – electrophysiology recording values.
Figure 3B – images and quantification of densities of CD45 
+ve cells and the proportions that contain wild type, Plp1 
transgenic myelin or latex beads.
Figure 4C – scans of X-ray films of proteome arrays follow-
ing treatment for 7 days with PBS, latex beads, wild type 
myelin or Plp1 tg myelin, plus raw values in arbitrary units and 
normalised values (to positive control spots) for spot intensity for 
each of the cytokines assayed, plus a template for cytokine array.
Figure 5 - scans of X-ray films and raw arbitrary unit values of 
band sizes and intensities.
Figure 6 and 7 – images from IN Cell Analyzer 2000 and 
CellProfiler values for myelin, axons and DAPI +ve nuclei.
Due the size of files for the microplate images these can not be 
provided but are available at request from the corresponding 
author (JE) julia.edgar@glasgow.ac.uk
Software availability
Analysis pipelines are available from Github: https://github.com/
muecs/cp/tree/v1.0
An archived version available of the pipelines are available 
from Zenodo: http://doi.org/10.5281/zenodo.2533339 (Mücklisch 
& Mücklisch, 2019)
Available under a ‘Creative Commons Attribution 3.0 Unported 
License’
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Supplementary material
Detailed protocols are provided in the following Supplementary Files:
Supplementary File 1. Preparing mouse spinal cord cultures
Click here to access the data
Supplementary File 2. Preparing custom-made dishes for live imaging
Click here to access the data
Supplementary File 3. Preparing and labelling a myelin-enriched spinal cord fraction
Click here to access the data
Supplementary File 4. Immunostaining myelinating cell cultures 
Click here to access the data
Supplementary File 5. Using CellProfiler analysis software
Click here to access the data
Supplementary Video 1: Live imaging of myelin phagocytosis 
Click here to access the data
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the system described.
Clarification regarding the value of having a system that is not part of a whole system (in the
research highlights this is presented as a strength, but why is not made explicit).
The cultures have been exploited for a number of features, and this is supported by the data that is
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 3.  
4.  
5.  
6.  
The cultures have been exploited for a number of features, and this is supported by the data that is
presented – however some analysis of the cellular organisation (2D/3D) of the cultures and the
variability in this would be very useful as other researchers consider whether the system is
appropriate for the experimental questions that want to address using the culture. It would also
enable the myelination to be seen in a different orientation, and support the data described. One
approach to this would be to section the cultures, possibly using an en-face approach as the
cultures are grown on coverslips. This approach has been used in other organoid/mini-brain culture
analyses.
A key issue with the development of new methods is the dissemination to other groups, the authors
report that the model could be readily adopted in other labs equipped for cell culture. Has this
happened? Irrespective of whether the model has been used to test a hypothesis elsewhere, it
would be useful to know that a second group working from the protocols has reported similar
findings, this will increase confidence in the model.
Re the methods, describe briefly the sterilisation step for the live imaging dishes.
Minor points a careful final proof-read is needed e.g. flurobite p5 needs to be corrected.
Are a suitable application and appropriate end-users identified?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are the 3Rs implications of the work described accurately?
Yes
Is the rationale for developing the new method (or application) clearly explained?
Yes
Is the description of the method technically sound?
Yes
Are sufficient details provided to allow replication of the method development and its use by
others?
Yes
If any results are presented, are all the source data underlying the results available to ensure full
reproducibility?
Yes
Are the conclusions about the method and its performance adequately supported by the
findings presented in the article?
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